The Race to Implant Is Quietly Accelerating

For decades, brain-computer interfaces were a lab curiosity. New data shows the number of human trials has more than doubled in a year, and a commercial arms race is in full swing.

A man with ALS performs his job as a climate activist using a brain implant. It allows him to reconnect with his family, to surf the web, to speak. For years, this was the bleeding edge of brain-computer interface research: a handful of courageous individuals in academic trials, pushing science forward one person at a time. That story is changing. The slow burn just ignited. Researchers once carefully tracked every implant over decades; now the numbers are expanding so fast it's hard to keep a precise count. One BCI researcher's current estimation is that the number of people with implants has more than doubled since the beginning of 2024 alone. The era of the bespoke, one-off brain implant is ending.

The core technology still operates on a fundamental trade-off. You can place electrodes in a non-invasive cap, on the surface of the brain, or directly into the gray matter itself. The closer you get to the neurons, the clearer your signal becomes, but the surgical risk climbs with every millimeter of depth. The most advanced systems, like those used by Neuralink and the academic consortium BrainGate, are invasive, threading tiny electrode arrays into the brain to pick up faint electrical whispers. That raw data is then piped to a computer—either through a physical port or wirelessly—where software trained on the user's specific neural patterns decodes intention into action, whether it's moving a cursor or forming a word.

This is no longer just a scientific endeavor; it's a market taking shape. Elon Musk's Neuralink commands the public's attention, and as Neuralink announced, it has implanted 21 people with its device in the past two years. But rivals like Synchron and Precision Neuroscience are running their own well-funded trials in the US. Critically, this is now a global race. According to MIT Technology Review, China became the first country to approve a BCI for medical use, granting a license to Shanghai-based Neuracle. This shifts the dynamic from academic collaboration to geopolitical competition. The fight isn't just to help patients—it's to establish the dominant platform that will connect human brains to computation.

The next five years will be about the messy transition from lab to life. A review published in Nature Communications found a roundup of all trials of BCIs conducted between 1998 and the end of 2023 totaled just 67 volunteers. The field is now adding more participants than that every year. We will see the hardware get smaller, more reliable, and fully wireless. We will also see recalls, security vulnerabilities, and the first true product liability cases for a device embedded in a person's skull. The real test is not whether the technology works, but what happens when a for-profit company controls the firmware that gives someone their voice back. Who gets to approve the next patch?